Menopoz Dönemindeki Kadınların Hormon Replasman Tedavisi Kullanma Niyetlerini Etkileyen Faktörleri Belirlenmesi

Abstract

Amaç: Bu çalışma, menopoz dönemindeki kadınların Hormon Replasman Tedavisi (HRT) kullanma niyetlerini etkileyen psikolojik, fizyolojik ve bilişsel faktörleri belirlemek amacıyla gerçekleştirilmiştir. Yöntemler: Kesitsel olarak tasarlanan bu çalışmada menopoz dönemindeki 429 kadın çalışmanın örneklemini oluşturmuştur. Veri toplamak için Menopoz Tutum Değerlendirme Ölçeği (MTDÖ), Menopoz Semptomları Değerlendirme Ölçeği (MSDÖ) ve Kişisel Bilgi Formu kullanılmıştır. Bulgular: Katılımcıların MTDÖ toplam puan ortalamaları 27.40±6.87, MSDÖ toplam puan ortalamaları ise 18.33±9.23 olarak bulunmuştur. Katılımcıların HRT niyet puanlarının ortalaması 2.83±1.63 olarak belirlenmiştir. Katılımcıların HRT niyetine göre menopoz tutumlarına ilişkin pozitif ve negatif duygusal faktörler, aile ilişkileri ve davranışsal faktörler alt boyut puanları istatistiksel olarak anlamlı bir fark göstermiştir (p<0.05). Çoklu regresyon analizinde MTDÖ puanı ile kadınların HRT’ye yönelik niyetleri arasında istatistiksel olarak anlamlı bir ilişki bulunmuş ve MTDÖ puanında meydana gelen her bir birimlik artışın HRT’ye yönelik niyette 0.043 birimlik azalmaya neden olduğu saptanmıştır. Sonuç: Bu çalışmadan elde edilen sonuçlar, menopoz döneminde kadınların sağlık davranışlarını etkileyen çok boyutlu faktörlerin dikkate alınması gerektiğini göstermektedir. Aynı zamanda HRT’ye yönelik bilgilendirici ve duyarlılıkla yapılandırılmış sağlık hizmetlerinin önemini vurgulamaktadır.

Keywords

• Hemşirelik
• Hormon Replasman Tedavisi
• kadın sağlığı
• klimakterik
• menopoz

Determining The Factors Affecting Women in The Menopause Period's Intention to Use Hormone Replacement Therapy

Abstract

Objective: This study was conducted to determine the psychological, physiological, and cognitive factors affecting the intention of menopausal women to use Hormone Replacement Therapy (HRT). Methods: This cross-sectional study consisted of 429 women in menopause. The Menopause Attitude Assessment Scale (MAAS), Menopause Symptoms Assessment Scale (MSAS), and Personal Information Form were used to collect data. Results: The participants' total MAAS score average was 27.40±6.87, and the MSAS total score average was 18.33±9.23. The participants' mean HRT intention score was determined as 2.83±1.63. According to the participants' HRT intention, the positive and negative emotional factors, family relations, and behavioral factors sub-dimension scores related to menopause attitudes showed a statistically significant difference (p<.05). In the multiple regression analysis, a statistically significant relationship was found between the MAAS score and women's intentions toward HRT, and it was determined that each unit increase in the MTRS score caused a 0.043 unit decrease in intentions toward HRT. Conclusion: The results obtained from this study show that multidimensional factors affecting women's health behaviors during menopause should be considered. It also emphasizes the importance of informative and sensitively structured health services regarding HRT.

Keywords

• Climacteric
• hormone replacement therapy
• menopause
• nursing
• women

References

1. Agrali, C., Unal, E., & Senol, D.K. (2022). Women's perception of menopause and their attitudes towards complementary therapy use. J Health Sci Inst., 7(3), 172-183. doi:10.51754/cusbed.1113442
2. Antoine, C., Ameye, L., Paesmans, M., de Azambuja, E., & Rozenberg, S. (2016). Menopausal hormone therapy use concerning breast cancer incidence in 11 European countries. Maturitas, 84, 81–88. https://doi.org/10.1016/j.maturitas.2015.11.010
3. Baghdadi, R., Singh, N., & Gatuguta, A. (2025). A grounded theory study exploring immigrant Muslim women’s perceptions and experiences of menopause, hormone replacement therapy, and menopause-related healthcare in the UK. Post Reprod Health, 31(1), 33-38. doi:10.1177/20533691251322823
4. Balmumcu, A. (2024). Menopoz semptomlarının yönetiminde kullanılan nonhormonal yöntemler. In A. Ş. Erenel (Ed.), Doğum kadın sağlığı hemşireliği: Geleneksel uygulamalardan bilim ve teknolojinin kullanımına (88–113). BIDGE Yayınevi.
5. Çelikkanat, Ş., & Sohbet, R. (2020). Determination of the Knowledge of and Attitudes and Behaviours towards Menopause among Women Aged 40 Years and Over. STED, 29(1), 31-37. doi: 10.17942/sted.560137
6. Çilgin, H. (2019). Predictors of initiating hormone replacement therapy in postmenopausal women: a cross-sectional study. Scientific World Journal, 1814804. 1-8. doi:10.1155/2019/1814804
7. Ekrem Cirban, E., & Özsoy, S. (2023). Do sexual myths affect menopause attitudes and symptoms? Clin Exp HealthSciences,13(2), 337-342. doi.org/10.33808/clinexphealthsci.1108157
8. Gürkan, Ö. (2005). Reliability and validity of the Turkish form of the Menopause Symptoms Assessment Scale. Nursing Forum, 30(5), 101-113.

9. Hamoda, H., Panay, N., Pedder, H., Arya, R., & Savvas, M. (2020). The British Menopause Society & Women’s Health Concern 2020 recommendations on hormone replacement therapy in menopausal women. Post Reprod Health, 26(4), 181-209. doi:10.1177/20533691211058030
10. Huang, D.R., Goodship, A., Webber, I., Alaa, A., Sasco, E.R., Hayhoe, B., & El-Osta, A. (2023). Experience and severity of menopause symptoms and effects on health-seeking behaviors: a cross-sectional online survey of community-dwelling adults in the United Kingdom. BMC Womens Health, 23(373), 2-10. doi.org/10.1177/2053369120957514
11. Hunter, M. S., & Liao, K. L. M. (1994). Intentions to use hormone replacement therapy in a community sample of 45-year-old women. Maturitas, 20(1), 13-23. doi.org/10.1016/0378-5122(94)90096-5
12. Iyer, T.K., & Manson, J.E. (2024). Recent trends in menopausal hormone therapy use in the US: insights, disparities, and implications for practice. JAMA Health Forum, 5(9), 1-3. doi:10.1001/jamahealthforum.2024.3135
13. Johnson, A., Roberts, L., & Elkins, G. (2019). Complementary and alternative medicine for menopause. J Evid Based Integr Med, 24. doi.org/10.1177/2515690X19829380
14. Koyuncu, T., Ünsal, A., & Arslantaş, D. (2015). Validity and reliability study of the Menopause Attitude Assessment Scale: A survey of women aged 40-64 in Eskişehir-Mahmudiye. TAF Preventive Medicine Bulletin, 14(6), 488-452. doi: 10.5455/pmb.1-1416265840
15. Lu, J., Li, K., Zheng, X., Liu, R., Chen, M., Xian, J., Tu, S., & Xie, L. (2023). Prevalence of menopausal symptoms and attitudes towards menopausal hormone therapy in women aged 40–60 years: a cross-sectional study. BMC Womens Health, 23(1), 472. doi: 10.1186/s12905-023-02621-8.
16. National Institute for Health and Care Excellence (NICE). Menopause: diagnosis and management. NICE guideline. Published November 12, 2015. Last updated December 5, 2023. Available from: https://www.nice.org.uk/guidance/ng23 Accessed: August 13, 2025.
17. Parish, S.J., Nappi, R.E., & Kingsberg, S. (2018). Perspectives on counseling patients about menopausal hormone therapy: strategies in a complex data environment. Menopause, 25(8), 937–949. doi: 10.1097/GME.0000000000001088
18. Peng, W., Adams, J., Hickman, L., & Sibbritt, D.W. (2014). Complementary, alternative and conventional medicine use among menopausal women: results from the Australian longitudinal study on women’s health. Maturitas, 79, 340–342. http://dx.doi.org/10.1016/j.maturitas.2014.08.002
19. Pinkerton, J.V. (2025). Hormone therapy. Menopause, 32(1), 95-97. 10.1097/GME.0000000000002474
20. Santoro, N., Epperson, C.N., & Mathews, S.B. (2015). Menopausal symptoms and their management. Endocrinol Metab Clin North Am., 44(3), 497–515. doi: 10.1016/j.ecl.2015.05.001
21. Selcen, M., Pala, E., & Ersoy, S. (2022). The relationship between menopausal attitudes and menopausal symptoms in women aged 40-55. Med Rec. 4(1), 81-89. doi.org/10.37990/medr.972596
22. Syed Alwi, S.A.R., Brohi, I.B., & Awi, I. (2021). Perception of menopause among women of Sarawak, Malaysia. BMC Womens Health, 21(1), 1-10. doi: 10.1186/s12905-021-01230-7
23. The North American Menopause Society (NAMS) (2022). The 2022 hormone therapy position statement of The North American Menopause Society. Menopause, 29(7), 767-794. doi:10.1097/GME.0000000000002028
24. Tunçarslan, N. (2019). The effect of social support per-ceived by menopausal women on the symptoms of menopause [Master’s thesis, Erzincan Binali Yıldırım University, Erzincan, Türkiye].
25. Turkish Menopause and Osteoporosis Association. Menopause (2025). https://www.tmod.org.tr/tr/sayfa/menopoz. Accessed March 12, 2025.
26. Tümer, A., & Kartal, A. (2018). The relation between women's attitudes towards menopause and their menopausal complaints. Pam Med J., 11(3), 337-346. doi: 10. 31362/patd.451911
27. Vaccaro, C.M., Capozzi, A., Ettore, G., Bernorio, R., Cagnacci, A., Gambacciani, M., Coletta, V., Maffei, S., Nappi, R. E., Scambia, G., Viora, E., & Lello, S. (2021). What women think about menopause: An Italian survey. Maturitas, 147, 47-52. https://doi.org/10.1016/j.maturitas.2021.03.007.
28. World Health Organization (WHO) (2024). Menopause. https://www.who.int/news-room/fact-sheets/detail/menopause. Accessed March 14, 2025.
29. Yagmur, S., & Akturk, U. (2021). The effects of some characteristics of women and menopause symptoms on menopausal attitude. Med Sci., 10(4), 1203- 1210. doi: 10.5455/medscience.2021.03.084.
30. Yang, L., & Toriola, A.T. (2024). Menopausal hormone therapy use among postmenopausal women. JAMA Health Forum, 5(9), e243128. doi:10.1001/jamahealthforum.2024.3128
31. Yasui, T., Ideno, Y., Shinozaki, H., Kitahara, Y., Nagai, K., & Hayashi, K. (2022). Prevalence of the use of oral contraceptives and hormone replacement therapy in Japan: the Japan Nurses’ Health Study. J Epi¬demiol, 32(3), 117-124. doi: 10.2188/jea.JE20200207.
32. Yaşar, Ö., & Yeyğel, Ç. (2024). Examination of Menopaus Symptoms and Menopaus Attitude with Life Satis-faction in Women between 45-60 Years. Istanbul Gelisim University Journal of Health Sci¬ences, 21, 1097-1111. doi:10.38079/igusab¬der.1231948s